TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”) is pleased to announce that the Ninepoint 2026 Flow-Through Limited Partnership (the “Partnership”) has filed a preliminary prospectus (the “Prospectus”) in connection with its offering of limited partnership units (the “Units”). A receipt for the Prospectus has been issued by the securities regulatory authorities…
NEW YORK, NY, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes only. It does not provide legal, medical, or employment advice. Product legality and permitted uses vary by jurisdiction. Readers should review applicable laws and official product documentation before making any purchase or use decision. This article contains affiliate links.…
RENO, NV, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This report is a consumer analysis for informational purposes only and does not constitute medical advice. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. Always consult a qualified healthcare professional before starting…
TORONTO, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Below are the confirmed annual special year-end distributions for the Middlefield ETFs for the 2025 tax year. These amounts are separate from the previously declared monthly cash distributions, which may include some allocation of capital gains, and are different from the previous estimates announced on December 4, 2025.
SAN DIEGO, Jan. 02, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the F5 class action lawsuit – captioned Smith v. F5, Inc., No. 25-cv-02619 (W.D. Wash.) – seeks to represent purchasers or acquirers of F5, Inc. (NASDAQ: FFIV) securities and charges F5 as well as certain…
PHILADELPHIA, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
